Feed aggregator
Low-risk DCIS patients may safely skip radiotherapy after surgery, study finds
Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received adjuvant radiotherapy, according to results from the E4112 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
New insights into how anti-obesity drugs could help prevent kidney disease
Data from Australian researchers could partly explain why a trial of a new drug for diabetes, was recently halted because it was found to be so effective.
Study identifies targetable fusion RNAs in breast cancer
Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique fusion mutations that may be therapeutically targetable, according to results presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
Study unlock secrets of Zika virus's multipurpose enzyme and reveals therapeutic vulnerability
Viruses have limited genetic material-;and few proteins-;so all the pieces must work extra hard. Zika is a great example; the virus only produces 10 proteins.
Women undergoing chemotherapy may not benefit from common fertility protection drug
A new study from Karolinska Institutet in Sweden has found no evidence that a common drug used to protect the ovaries of women undergoing chemotherapy increases their chances of having children after cancer treatment.
New discovery could provide a potential target to treat diabetes
Researchers at Case Western Reserve University and University Hospitals have identified an enzyme that blocks insulin produced in the body-;a discovery that could provide a new target to treat diabetes.
Closing the gender gap in HIV treatment could slash infection rates in Uganda
A study looking at 15 years of HIV transmission and suppression in Uganda reveals how closing gender gaps in treatment could slash infection rates.